SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNuformix Share News (NFX)

Share Price Information for Nuformix (NFX)

Share Price is delayed by 15 minutes
Get Live Data
0.205    0.003 (1.49%)
Bid:
0.19
Ask:
0.22
Spread: 0.03 (15.789%)
Market Cap: £5.35m
NFX Live PriceLast checked at - London Stock Exchange

Intraday Nuformix Share Chart

Nuformix News

SMALL-CAP WINNERS & LOSERS: William Hill owner Evoke closes shops
27 Jan 2026

SMALL-CAP WINNERS & LOSERS: William Hill owner Evoke closes shops

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Tuesday.

IN BRIEF: Nuformix raises GBP228,000 in open offer
12 Nov 2025

IN BRIEF: Nuformix raises GBP228,000 in open offer

Nuformix PLC - London-based developer of treatments for fibrosis and oncology - Raises approximately GBP228,081 through an underwritten open offer at ...

TRADING UPDATES: Celsius raises funds; Built Cybernetics acquisition
12 Nov 2025

TRADING UPDATES: Celsius raises funds; Built Cybernetics acquisition

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

IN BRIEF: Nuformix submits FDA drug designation application for NXP002
11 Aug 2025

IN BRIEF: Nuformix submits FDA drug designation application for NXP002

Nuformix PLC - London-based developer of treatments for fibrosis and oncology - Submits US Food & Drug Administration orphan drug designation applicat...

Nuformix shares fall despite EU orphan drug status for lead treatment
29 May 2025

Nuformix shares fall despite EU orphan drug status for lead treatment

(Alliance News) - Nuformix PLC on Thursday said its lead programme, NXP002, has been granted orphan drug designation by the European Medicines Agency ...

Nuformix interim loss widens as focused on advancing assets
2 May 2025

Nuformix interim loss widens as focused on advancing assets

(Alliance News) - Nuformix PLC on Friday said it has continued to "advance and exploit" assets in its portfolio, two days after noting a positive opin...

Nuformix finds positive data for NXP002 in lung fibrosis study
9 Apr 2025

Nuformix finds positive data for NXP002 in lung fibrosis study

(Alliance News) - Nuformix PLC on Wednesday said fresh analysis of lung tissue from patients with idiopathic pulmonary fibrosis and autoimmune-related...